Last edition
News about "Zytorvi for ESCC"
Dr. Reddy's Gets DCGI Approval for Zytorvi in Esophageal Cancer
Dr. Reddy’s has received DCGI approval for Zytorvi (toripalimab) in advanced esophageal cancer, marking its second approved indication in India.
Zytorvi For ESCC | 21/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members